Target
Bromodomain-containing protein 4 [44-164]
Ligand
BDBM425425
Substrate
n/a
Meas. Tech.
Alphascreen Binding Assay
IC50
<1000±n/a nM
Citation
 Zhang, JBuell, JChan, KIbrahim, PNLin, JPham, PShi, SSpevak, WWu, GWu, J Heterocyclic compounds and uses thereof US Patent  US10519177 Publication Date 12/31/2019 
Target
Name:
Bromodomain-containing protein 4 [44-164]
Synonyms:
BRD4 | BRD4_HUMAN | Bromodomain-containing protein 4 (aa 44-164) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14412.06
Organism:
Homo sapiens (Human)
Description:
BRD4-BD1 (44-164)
Residue:
121
Sequence:
NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINEL
  
Inhibitor
Name:
BDBM425425
Synonyms:
US10519177, Compound P-0330 | US10519177, Compound P-0538 | methyl 4-[1-[(4,4- difluorocyclohexyl)methyl]-6-(3,5- dimethylisoxazol-4-yl)pyrrolo[3,2- b]pyridin-3-yl]benzoate
Type:
Small organic molecule
Emp. Form.:
C27H27F2N3O3
Mol. Mass.:
479.5184
SMILES:
COC(=O)c1ccc(cc1)-c1cn(CC2CCC(F)(F)CC2)c2cc(cnc12)-c1c(C)noc1C
Structure:
Search PDB for entries with ligand similarity: